scholarly journals Coagulation and fibrinolysis in human acute lung injury-New therapeutic targets?

2005 ◽  
Vol 54 (3) ◽  
pp. 142-149 ◽  
Author(s):  
Lorraine B. Ware ◽  
Julie A. Bastarache ◽  
Ling Wang
2005 ◽  
Vol 16 (1) ◽  
pp. 3-10
Author(s):  
Goda Choi ◽  
Esther K. Wolthuis ◽  
Marcel Levi ◽  
Tom Van Der Poll ◽  
Marcus J. Schultz

2008 ◽  
Vol 152 (6) ◽  
pp. 255-256
Author(s):  
Patrick Singleton ◽  
Joe G.N. Garcia

Critical Care ◽  
2008 ◽  
Vol 12 (2) ◽  
pp. R41 ◽  
Author(s):  
Dana McClintock ◽  
Hanjing Zhuo ◽  
Nancy Wickersham ◽  
Michael A Matthay ◽  
Lorraine B Ware

2006 ◽  
Vol 291 (3) ◽  
pp. L307-L311 ◽  
Author(s):  
Lorraine B. Ware ◽  
Eric Camerer ◽  
Karen Welty-Wolf ◽  
Marcus J. Schultz ◽  
Michael A. Matthay

Substantial progress has been made in understanding the contribution of alterations in coagulation and fibrinolysis to the pathogenesis of acute lung injury (ALI). Findings from mouse, rat, baboon, and human studies indicate that alterations in coagulation and fibrinolysis may be of major pathogenetic importance in ALI and other inflammatory conditions in the lung including pneumonia, sepsis, and ventilator-induced lung injury. Therapies targeted at both activation of coagulation through the extrinsic coagulation cascade and modulation of coagulation through the protein C system have the potential to favorably impact clinical ALI/acute respiratory distress syndrome.


Sign in / Sign up

Export Citation Format

Share Document